1 Day
Source:
الشورى
_1777352244987_250242181.png&w=64&q=75){kind=small}
_1777352142843_145525226.png&w=64&q=75){kind=small}
Source: الشورى
1 Dayالشورى
Source: الشورى
1 DayReady to play
Ready to play
The article discusses the strategic partnership between Egypt and China in the healthcare sector, emphasizing significant developments such as China's support for Egypt during the COVID-19 pandemic by providing 300,000 doses of Sinopharm vaccine, and the signing of agreements to locally manufacture vaccines through Fakhria Company. It also highlights the China-funded Level 3 Biosafety Laboratory project aimed at enhancing Egypt's diagnostic capabilities and health security. Additionally, the article covers major Chinese investments in localizing healthcare industries, such as the "Jia Egypt" project valued at $67 million. The report also explores cooperation with Huawei in digital health technology, stressing the importance of developing human resources and protecting data, with the goal of building an integrated healthcare system based on manufacturing, research, and training—thereby supporting Egypt's position as a regional hub for medical and pharmaceutical industries.
Notice: This Is an AI-Generated Summary
Comments (0)